EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection

Yuanyuan Wang, Roxanne V Kyauk, Yun-An A Shen, Luke Xie, Mike Reichelt, Han Lin, Zhiyu Jiang, Hai Ngu, Kimberle Shen, Jacob J Greene, Morgan Sheng, Tracy J Yuen iD

Glia · 2023-05 · 71 (5) · 1247-1258

DOI: 10.1002/glia.24335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, online erschienen am 10.01.2023. Verfasst von Yuanyuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Genentech Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Remyelination, Multiple Sclerosis. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disability in multiple sclerosis (MS) is driven in part by the failure of remyelination and progressive neurodegeneration. Microglia, and specifically triggering receptor expressed on myeloid cells 2 (TREM2), a factor highly expressed in microglia, have been shown to play an important role in remyelination. Here, using a focal demyelination model in the brain, we demonstrate that demyelination is persistent in TREM2 knockout mice, lasting more than 6 weeks after lysolecithin injection and resulting in substantial neurodegeneration. We also find that TREM2 knockout mice exhibit an altered glial response following demyelination. TREM2 knockout microglia demonstrate defects in migration and phagocytosis of myelin debris. In addition, human monocyte‐derived macrophages from subjects with a TREM2 mutation prevalent in human disease also show a defect in myelin debris phagocytosis. Together, we highlight the central role of TREM2 signaling in remyelination and neuroprotection. These findings provide insights into how chronic demyelination might lead to axonal damage and could help identify novel neuroprotective therapeutic targets for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RemyelinationMultiple SclerosisAnimalsMiceHumansMicrogliaNeuroprotectionMyelin SheathMice, KnockoutMice, Inbred C57BLMembrane GlycoproteinsReceptors, Immunologic

Stichwörter der Autor:innen

TREM2axon degenerationdemyelinationmicrogliamultiple sclerosisoligodendrocytesremyelination

Substanzen

TREM2 protein, humanMembrane GlycoproteinsReceptors, ImmunologicTrem2 protein, mouse

Autor:innen und Institutionen

  • Department of Neuroscience, Genentech Inc., South San Francisco, California, USA.
  • Department of Biomedical Imaging, Genentech Inc., South San Francisco, California, USA.
  • Department of Pathology, Genentech Inc., South San Francisco, California, USA.
  • Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

ORCID-Profile: Tracy J Yuen

Zitieren

APA

Wang, Y., Kyauk, R. V., Shen, Y. A., Xie, L., Reichelt, M., Lin, H., Jiang, Z., Ngu, H., Shen, K., Greene, J. J., Sheng, M., & Yuen, T. J. (2023). TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection. Glia, 71(5), 1247-1258. https://doi.org/10.1002/glia.24335

Vancouver

Wang Y, Kyauk RV, Shen YA, Xie L, Reichelt M, Lin H, et al. TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection. Glia. 2023;71(5):1247-1258. doi:10.1002/glia.24335

BibTeX
@article{Wang2023,
  author = {Wang, Yuanyuan and Kyauk, Roxanne V and Shen, Yun-An A and Xie, Luke and Reichelt, Mike and Lin, Han and Jiang, Zhiyu and Ngu, Hai and Shen, Kimberle and Greene, Jacob J and Sheng, Morgan and Yuen, Tracy J},
  title = {TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection},
  journal = {Glia},
  year = {2023},
  volume = {71},
  number = {5},
  pages = {1247--1258},
  doi = {10.1002/glia.24335}
}
Kostenlos starten →